Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Topol EJ, Ohman EM, Armstrong PW, Wilcox R, Skene AM, Aylward P, Simes J, Dalby A, Betriu A, Bode C, White HD, Hochman JS, Emanuelson H, Vahanian A, Sapp S, Stebbins A, Moliterno DJ, Califf RM. Topol EJ, et al. Among authors: armstrong pw. Circulation. 2000 Oct 10;102(15):1761-5. doi: 10.1161/01.cir.102.15.1761. Circulation. 2000. PMID: 11023929 Clinical Trial.
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, Gore JM, Armstrong PW, Ohman EM, Topol EJ. Pilote L, et al. Among authors: armstrong pw. N Engl J Med. 1995 Aug 31;333(9):565-72. doi: 10.1056/NEJM199508313330907. N Engl J Med. 1995. PMID: 7623907 Free article.
Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy.
Steinberg JS, Hochman JS, Morgan CD, Dorian P, Naylor CD, Theroux P, Topol EJ, Armstrong PW. Steinberg JS, et al. Among authors: armstrong pw. Circulation. 1994 Aug;90(2):746-52. doi: 10.1161/01.cir.90.2.746. Circulation. 1994. PMID: 8044943 Clinical Trial.
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.
Topol EJ, Califf RM, Van de Werf F, Simoons M, Hampton J, Lee KL, White H, Simes J, Armstrong PW. Topol EJ, et al. Among authors: armstrong pw. Circulation. 1997 Feb 18;95(4):1072-82. doi: 10.1161/01.cir.95.4.1072. Circulation. 1997. PMID: 9054772 Review. No abstract available.
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.
Berkowitz SD, Granger CB, Pieper KS, Lee KL, Gore JM, Simoons M, Armstrong PW, Topol EJ, Califf RM. Berkowitz SD, et al. Among authors: armstrong pw. Circulation. 1997 Jun 3;95(11):2508-16. doi: 10.1161/01.cir.95.11.2508. Circulation. 1997. PMID: 9184581
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, Armstrong PW. Goodman SG, et al. Among authors: armstrong pw. Circulation. 1998 Feb 10;97(5):444-50. doi: 10.1161/01.cir.97.5.444. Circulation. 1998. PMID: 9490238 Clinical Trial.
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Metz BK, White HD, Granger CB, Simes RJ, Armstrong PW, Hirsh J, Fuster V, MacAulay CM, Califf RM, Topol EJ. Metz BK, et al. Among authors: armstrong pw. J Am Coll Cardiol. 1998 Jun;31(7):1493-8. doi: 10.1016/s0735-1097(98)00138-7. J Am Coll Cardiol. 1998. PMID: 9626825 Free article. Clinical Trial.
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.
Hasdai D, Holmes DR Jr, Topol EJ, Berger PB, Criger DA, Hochman JS, Bates ER, Vahanian A, Armstrong PW, Wilcox R, Ohman EM, Califf RM. Hasdai D, et al. Among authors: armstrong pw. Eur Heart J. 1999 Jan;20(2):128-35. doi: 10.1053/euhj.1999.1282. Eur Heart J. 1999. PMID: 10099909 Clinical Trial.
883 results